Oral versus intravenous steroids for treatment of relapses in multiple sclerosis - Burton, JM - 2012
| Cochrane Library Skip to Content Cookies Our site uses cookies to improve your experience …

Multiple sclerosis (MS) is a chronic autoimmune, inflammatory neurological disease of the
central nervous system (CNS). 1, 2 MS attacks the myelinated axons in the CNS, destroying …

Multiple sclerosis (MS) is an autoimmune, inflammatory demyelinating disease of the central
nervous system characterized in the majority of the patients by a relapsing-remitting disease …

Rationale Pulse glucocorticoid therapy is used in hyperinflammation related to coronavirus
disease 2019 (COVID-19). We evaluated the efficacy and safety of pulse intravenous …

Background An intravenous rather than oral course of methylprednisolone is often
prescribed for treating acute relapses in multiple sclerosis (MS) despite the lack of evidence …

Relapses, exacerbations or attacks of multiple sclerosis are the dominating feature of
relapsing‐remitting multiple sclerosis (MS), but are also observed in patients with secondary …

Intravenous supra-pharmacological doses of corticosteroids are used in various
inflammatory and autoimmune conditions because they are cumulatively less toxic than …

Background Apoptosis is supposed to contribute to the elimination of T cells from the
inflamed central nervous system in the natural disease course of multiple sclerosis (MS). In …

Despite recent advances in multiple sclerosis treatment, patients experience relapses for
which standard treatment remains glucocorticosteroids (GCS). However, there is limited …

■ ABSTRACT Recent advances in our understanding of the diagnosis, imaging, pathology,
and clinical monitoring of multiple sclerosis (MS) have significantly increased our ability to …